Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Project Grant

McMaster University

$180,000.00

The impact of outpatient prescription drug insurance on drug and health services use in Ontario children and youth

FY 2024-25

Summary
In Canada, drug insurance varies widely with a mix of coverage by public and private drug programmes. In Ontario, about 25% residents aged 12 to 24 years report having no drug insurance coverage, while about 56% report having drug private coverage. Most private coverage is obtained via employers or as the dependent of an employee with a private drug plan; for children and youth, this is most often a parent or guardian. Private drug plans proactively report any drug claims to the primary plan holder. For dependents wishing to access drugs confidentially, this may present an additional challenge and may result in lower access or high out-of-pocket expenses in an effort to maintain confidentiality. Even if confidentiality is not a barrier, most private drug plans include some form of cost-sharing (e.g., coinsurance) and annual limits. In January 2018, the Ontario government introduced universal pharmacare for all prescription drugs listed on Ontario's public drug formulary, to all Ontario children and youth under the age of 25 without copayments, including individuals already covered via private drug plans. In April 2019, the programme was revised to cover only children and youth who did not otherwise have access to private drug insurance. As a result many Ontario children and youth reverted back to their previous private drug plan or, in many cases, their parent's private plan. Confidential access to prescription medication for these individuals may have been compromised and copayments reintroduced. Our interdisciplinary project will generate policy-relevant evidence regarding the impact of universal, comprehensive, free, and confidential prescription drug insurance on drug and health services use for policymakers and health advocates as Canada continues to evaluate how best to provide drug coverage for all citizens.
Program
Project Grant
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
524155
Name
Guindon Godefroy E
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Health Policy & Systems Management Research
Projecttitle
The impact of outpatient prescription drug insurance on drug and health services use in Ontario children and youth
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$180,000
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Children; Equity; Health Services Use; Healthcare Use; Insurance; Mental Health; Prescription Drug; Youth
Abstract
In Canada, drug insurance varies widely with a mix of coverage by public and private drug programmes. In Ontario, about 25% residents aged 12 to 24 years report having no drug insurance coverage, while about 56% report having drug private coverage. Most private coverage is obtained via employers or as the dependent of an employee with a private drug plan; for children and youth, this is most often a parent or guardian. Private drug plans proactively report any drug claims to the primary plan holder. For dependents wishing to access drugs confidentially, this may present an additional challenge and may result in lower access or high out-of-pocket expenses in an effort to maintain confidentiality. Even if confidentiality is not a barrier, most private drug plans include some form of cost-sharing (e.g., coinsurance) and annual limits. In January 2018, the Ontario government introduced universal pharmacare for all prescription drugs listed on Ontario's public drug formulary, to all Ontario children and youth under the age of 25 without copayments, including individuals already covered via private drug plans. In April 2019, the programme was revised to cover only children and youth who did not otherwise have access to private drug insurance. As a result many Ontario children and youth reverted back to their previous private drug plan or, in many cases, their parent's private plan. Confidential access to prescription medication for these individuals may have been compromised and copayments reintroduced. Our interdisciplinary project will generate policy-relevant evidence regarding the impact of universal, comprehensive, free, and confidential prescription drug insurance on drug and health services use for policymakers and health advocates as Canada continues to evaluate how best to provide drug coverage for all citizens.
Competitiondate
202503
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Guindon, Godefroy E; de Oliveira, Claire; Fuller, Anne E; Georgiades, Katholiki K
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $180,000~ $0~
McMaster University - $180,000 Grant (2024-25) | Canada Spends